General Information of the Compound
| Compound ID |
CP0437467
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-4-(4'-Fluoro-5-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)-N-(pyrimidin-2-yl)chromane-7-sulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H19F4N3O3S
|
||||||||||||||||||
| Molecular Weight |
529.515
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc(cc1)-c1cc(ccc1[C@H]1CCOc2cc(ccc12)S(=O)(=O)Nc1ncccn1)C(F)(F)F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H19F4N3O3S/c27-18-5-2-16(3-6-18)23-14-17(26(28,29)30)4-8-20(23)21-10-13-36-24-15-19(7-9-22(21)24)37(34,35)33-25-31-11-1-12-32-25/h1-9,11-12,14-15,21H,10,13H2,(H,31,32,33)/t21-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
CZZSYEPBDUZHLQ-OAQYLSRUSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01105, Sodium channel protein type 5 subunit alpha
Protein ID: PT01000, Sodium channel protein type 9 subunit alpha